235 related articles for article (PubMed ID: 28217292)
1. Oxygen or cooling, to make a decision after acute ischemia stroke.
Liu WC; Jin XC
Med Gas Res; 2016; 6(4):206-211. PubMed ID: 28217292
[TBL] [Abstract][Full Text] [Related]
2. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
3. Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis?
Jin X; Liu J; Liu W
Curr Neurovasc Res; 2014; 11(3):254-62. PubMed ID: 24875486
[TBL] [Abstract][Full Text] [Related]
4. Normobaric Hyperoxia Reduces Blood Occludin Fragments in Rats and Patients With Acute Ischemic Stroke.
Shi S; Qi Z; Ma Q; Pan R; Timmins GS; Zhao Y; Shi W; Zhang Y; Ji X; Liu KJ
Stroke; 2017 Oct; 48(10):2848-2854. PubMed ID: 28931617
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.
Fujiwara N; Murata Y; Arai K; Egi Y; Lu J; Wu O; Singhal AB; Lo EH
BMC Neurosci; 2009 Jul; 10():79. PubMed ID: 19604385
[TBL] [Abstract][Full Text] [Related]
6. Cocktail treatment, a promising strategy to treat acute cerebral ischemic stroke?
Liang LJ; Yang JM; Jin XC
Med Gas Res; 2016 Mar; 6(1):33-38. PubMed ID: 27826421
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of tPA in ischemic stroke is enhanced by its combination with normobaric oxygen and hypothermia or ethanol.
Ji Z; Liu K; Cai L; Peng C; Xin R; Gao Z; Zhao E; Rastogi R; Han W; Rafols JA; Geng X; Ding Y
Brain Res; 2015 Nov; 1627():31-40. PubMed ID: 26319679
[TBL] [Abstract][Full Text] [Related]
8. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
9. tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
Kim JS
J Stroke; 2019 May; 21(2):160-174. PubMed ID: 31161761
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment.
Knecht T; Story J; Liu J; Davis W; Borlongan CV; Dela Peña IC
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257093
[TBL] [Abstract][Full Text] [Related]
11. A review of oxygen therapy in ischemic stroke.
Singhal AB
Neurol Res; 2007 Mar; 29(2):173-83. PubMed ID: 17439702
[TBL] [Abstract][Full Text] [Related]
12. Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need.
Peña ID; Borlongan C; Shen G; Davis W
J Stroke; 2017 Jan; 19(1):50-60. PubMed ID: 28178410
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapies using normobaric oxygen with hypothermia or ethanol for reducing hyperglycolysis in thromboembolic cerebral ischemia.
Cai L; Stevenson J; Peng C; Xin R; Rastogi R; Liu K; Geng X; Gao Z; Ji X; Rafols JA; Ji Z; Ding Y
Neuroscience; 2016 Mar; 318():45-57. PubMed ID: 26794589
[TBL] [Abstract][Full Text] [Related]
14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
15. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.
Henninger N; Bratane BT; Bastan B; Bouley J; Fisher M
J Cereb Blood Flow Metab; 2009 Jan; 29(1):119-29. PubMed ID: 18766195
[TBL] [Abstract][Full Text] [Related]
16. Prothrombolytic action of normobaric oxygen given alone or in combination with recombinant tissue-plasminogen activator in a rat model of thromboembolic stroke.
David HN; Haelewyn B; Degoulet M; Colomb DG; Risso JJ; Abraini JH
J Appl Physiol (1985); 2012 Jun; 112(12):2068-76. PubMed ID: 22492935
[TBL] [Abstract][Full Text] [Related]
17. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
18. Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke.
Kuo PC; Weng WT; Scofield BA; Furnas D; Paraiso HC; Intriago AJ; Bosi KD; Yu IC; Yen JH
Blood Adv; 2020 Sep; 4(18):4366-4381. PubMed ID: 32926126
[TBL] [Abstract][Full Text] [Related]
19. Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model.
Dong W; Qi Z; Liang J; Shi W; Zhao Y; Luo Y; Ji X; Liu KJ
Exp Neurol; 2015 Oct; 272():181-9. PubMed ID: 25891441
[TBL] [Abstract][Full Text] [Related]
20. Normobaric hyperoxia retards the evolution of ischemic brain tissue toward infarction in a rat model of transient focal cerebral ischemia.
Xu J; Zhang Y; Liang Z; Wang T; Li W; Ren L; Huang S; Liu W
Neurol Res; 2016 Jan; 38(1):75-9. PubMed ID: 27078693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
